US Patent Issued to Atriva Therapeutics on July 8 for "MEK-inhibitor for the treatment of viral and bacterial infections" (German Inventor)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,244, issued on July 8, was assigned to Atriva Therapeutics GmbH (Tubingen, Germany).

"MEK-inhibitor for the treatment of viral and bacterial infections" was invented by Oliver Planz (Dettingen an der Erms, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to PD-0184264 for use in a method for the treatment of a viral infection or a viral and bacterial coinfection. Also provided are compositions comprising such inhibitors for use in the treatment of a virus infection and the prevention and/or treatment of a bacterial co-infection."

The patent was filed on April 16, 2020, under Application No. 17/604,355.

*For furth...